Skip to main content

Takeda Pharmaceutical Co Ltd

TKPHF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001395064

In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 19 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesTAK

13F holders, Q2 2026

Institutional positions in Takeda Pharmaceutical Co Ltd as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
0
0 vs. Q1 2026
Shares held
0
0 vs. Q1 2026
Total value
$0
$0 vs. Q1 2026
New holders
0
0 more added
Sold out
0
0 more reduced

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Takeda Pharmaceutical Co Ltd; share changes are against Q1 2026.

No institution reported holding TKPHF in Q2 2026.